JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131101

Anti-PKC mu/PKD (phospho S738) antibody

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Polyclonal PKC mu/PKD phospho S738 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human PRKD1 phospho S738 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

PKD, PKD1, PRKCM, PRKD1, Serine/threonine-protein kinase D1, Protein kinase C mu type, Protein kinase D, nPKC-D1, nPKC-mu

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-PKC mu/PKD (phospho S738) antibody (AB131101)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PKC mu/PKD (phospho S738) antibody (AB131101)

Immunofluorescence analysis of methanol-fixed HeLa cells labelling PKC mu/PKD (phospho S738) with ab131101 at 1/100 dilution.

Western blot - Anti-PKC mu/PKD (phospho S738) antibody (AB131101)
  • WB

Supplier Data

Western blot - Anti-PKC mu/PKD (phospho S738) antibody (AB131101)

All lanes:

Western blot - Anti-PKC mu/PKD (phospho S738) antibody (ab131101) at 1/500 dilution

Lane 1:

MCF cell extract untreated

Lane 2:

MCF cell extract treated with PMA

Predicted band size: 102 kDa

Observed band size: 115 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF

applications

Immunogen

Synthetic Peptide within Human PRKD1 phospho S738 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

Q15139

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/200", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab131101 was purified by affinity-chromatography using epitope-specific phosphopetide. Non-phospho specific antibodies were removed by chromatography using non-phosphopetide.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PKC mu also known as Protein Kinase D (PKD) is a serine/threonine protein kinase with a notable role in various cellular processes. It is also referred to as PKD 62 due to its molecular mass of approximately 62 kDa. This kinase expresses widely in human tissues with high levels observed in the liver skeletal heart muscle and pancreas. During key cellular actions PKC mu moves between different cellular compartments mediating essential signaling events.
Biological function summary

PKC mu influences several cellular processes including cell proliferation migration and survival. It forms part of a larger protein complex involved in diverse signaling pathways. PKC mu regulates gene expression by affecting various transcription factors. Its activity impacts pathways connected to cell growth and responses to stress demonstrating an essential role in maintaining cellular homeostasis.

Pathways

PKC mu plays an important role in both the MAPK and NF-kB signaling pathways. Through these pathways it interacts with proteins such as Ras and IKK contributing to cell growth and inflammation. PKC mu acts as a bridge allowing signals to be transmitted efficiently ensuring appropriate responses to extracellular stimuli.

PKC mu has been linked to cancer and cardiac hypertrophy. Alterations in PKC mu activity contribute to pathological states due to its involvement in pathways that manage cell growth and stress responses. For instance its overexpression or hyperactivity associates with tumor development and progression. PKC mu's relationship with proteins like Akt in cancer pathways further implicates it in oncogenic processes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response (PubMed : 10764790, PubMed : 12505989, PubMed : 12637538, PubMed : 17442957, PubMed : 18509061, PubMed : 19135240, PubMed : 19211839). Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation (PubMed : 10523301). Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-463 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1 (PubMed : 12505989). Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenetic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2 (PubMed : 18509061). In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling (PubMed : 18332134). Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation (PubMed : 19211839). In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents (PubMed : 10764790). In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines (PubMed : 17442957). Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 (By similarity). May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor (PubMed : 15471852). Plays a role in activated KRAS-mediated stabilization of ZNF304 in colorectal cancer (CRC) cells (PubMed : 24623306). Regulates nuclear translocation of transcription factor TFEB in macrophages upon live S.enterica infection (By similarity).
See full target information PRKD1 phospho S738

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Biomedical research (Tokyo, Japan) 46:225-232 PubMed41016776

2025

Micheliolide alleviates oxygen-glucose deprivation/reoxygenation-evoked inflammation and ROS production in H9c2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qu Jin,Jinzhu Yin,Zhaozheng Liu,Chao Tang

Journal of cellular physiology 235:2414-2428 PubMed31517390

2019

Upregulated microRNA-31 inhibits oxidative stress-induced neuronal injury through the JAK/STAT3 pathway by binding to PKD1 in mice with ischemic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Li,Hui Lv,Yu-Qin Che
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com